Dark

Check out our Level2View

SMTI
Sanara MedTech Inc. Common Stock
stock NASDAQ

Market Open

Jul 30, 2026 1:35:49 PM EDT

33.80USD+11.221%(+3.41)2,438,122

28.77Bid 38.42Ask 9.65Spread

Pre-market

Jul 30, 2026 9:29:30 AM EDT

33.55USD+10.398%(+3.16)23,253

After-hours

Jul 29, 2026 4:58:30 PM EDT

33.00USD+8.588%(+2.61)0

OverviewHistoricalExchangesShortsNews

Dec 28, 2021

09:20AM EST Sanara MedTech Names Zachary Fleming As CEO Benzinga

09:15AM EST Sanara MedTech Inc. (Sanara or the Company) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today that Zachary (Zach) B. Fleming has been appointed Chief Executive Officer effective January 1, 2022. GlobeNewswire Inc

Dec 22, 2021

04:05PM EST Sanara MedTech Inc. Announces the Retirement of J. Michael Carmena GlobeNewswire Inc

Dec 15, 2021

09:15AM EST Sanara MedTech Inc. (Sanara or the Company) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today that Roszell Mack III has been appointed to the Companys Board of Directors (the Board), effective January 1, 2022. GlobeNewswire Inc

Nov 15, 2021

09:43AM EST Sanara MedTech Q3 EPS $(0.27) Misses $(0.18) Estimate, Sales $5.82M Miss $6.30M Estimate Benzinga

Nov 12, 2021

04:26AM EST Earnings Scheduled For November 12, 2021 Benzinga

Aug 16, 2021

04:04AM EDT Earnings Scheduled For August 16, 2021 Benzinga

Jun 30, 2021

10:56AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2021 Benzinga

07:30AM EDT Cantor Fitzgerald Initiates Coverage On Sanara MedTech with Overweight Rating, Announces Price Target of $45 Benzinga

Jun 4, 2021

09:18AM EDT Sanara MedTech Announces Exclusive Partnership With Pixalere Healthcare To Advance Comprehensive Wound And Skin Care Strategy Benzinga

Feb 12, 2021

10:59AM EST Mid-Morning Market Update: US Stock Futures Trend Down; Nasdaq Composite Dips 0.2% Benzinga

10:16AM EST Sanara MedTech Earlier Priced 1.1M Share Common Stock Offering At $25/Share Benzinga

Feb 11, 2021

04:11PM EST Sanara MedTech Inc. Announces Proposed Public Offering of Common Stock; No terms Disclosed Benzinga

Jan 25, 2021

04:12PM EST Sanara MedTech Sees Q4 2020 Revs. ~$4.8M Vs $3.4M YoY Benzinga

Dec 23, 2020

08:31AM EST The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut Benzinga

Dec 18, 2020

07:48AM EST The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data Benzinga

07:45AM EST The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data Benzinga

Nov 5, 2020

09:21AM EST Sanara MedTech Announces Launch Of BIAKOS Antimicrobial Wound Gel; Says 'Results using the liquid form of BIAKOS showed a 98.4% reduction in viral load on a porcine skin explant after 30 seconds' Benzinga

Share